Cambridge, Massachusetts, United States Novartis Institutes appeared to be the Corporate Investor, which was created in 2002. The main department of described Corporate Investor is located in the Cambridge. The fund was located in North America if to be more exact in United States.
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Novartis Institutes, startups are often financed by MPM Capital, OUP (Osage University Partners), 5AM Ventures. The meaningful sponsors for the fund in investment in the same round are WuXi Healthcare Ventures, Pfizer Venture Investments, OUP (Osage University Partners). In the next rounds fund is usually obtained by WuXi Healthcare Ventures, Roche Venture Fund, Perceptive Advisors.
Among the most popular portfolio startups of the fund, we may highlight Blade Therapeutics, IDEAYA Biosciences. Among the most successful fund investment fields, there are Pharmaceutical, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 1 and less years to get the investment from the fund.
The increased amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2016.
Related Funds
| Fund Name | Location |
| Andgo Partners | Budapest, Hungary |
| Changjiangyun | China, Hubei, Wuhan |
| Climate Adaptive Infrastructure | - |
| Colt Ventures | Dallas, Texas, United States |
| Compass Global Fund | - |
| Concrete Venture Capital | England, London, United Kingdom |
| Flatiron Partners | New York, New York, United States |
| Hecai Jijin | - |
| INTAGE Open Innovation Fund | - |
| Invertidos | Andalucia, Málaga, Spain |
| Shanghai Only Education Group | China, Shanghai |
| Shanghai Yuanlian Touzi Youxian Gongsi | Baoshan, China, Shanghai |
| Shenzhenshi Licheng Zhihe Chuangtou | China, Guangdong, Tianjin |
| SK Telecom Ventures | California, Sunnyvale, United States |
| Unanounced | - |
| UpHonest Capital | California, San Francisco, United States |
| VIR | - |
| Yongxin Zichan | China, Ningbo, Zhejiang |
| zVentures | California, San Francisco, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Blade Therapeutics | $45M | 16 Jun 2016 | South San Francisco, California, United States | ||
IDEAYA Biosciences | $46M | 03 May 2016 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Blade Therapeutics | $45M | 16 Jun 2016 | South San Francisco, California, United States | ||
IDEAYA Biosciences | $46M | 03 May 2016 | South San Francisco, California, United States |
